产品中心您的位置:网站首页 > 产品中心 > 生物试剂 > 其他生化试剂 > 1410880-22-6JNK-IN-8 1410880-22-6

JNK-IN-8 1410880-22-6

更新时间:2024-04-18

访问量:502

厂商性质:经销商

生产地址:

简要描述:
JNK-IN-8 1410880-22-6
上海一基实业有限公司是主要从事配套试剂的生产和销售的企业,产品用途:科研实验,标准对照品研究中心代理的作为一种衡量标准

JNK-IN-8  1410880-22-6

JNK-IN-8
分子式:C29H29N7O2    分子量:507.59
 
产品描述
JNK-IN-8是*个,不可逆JNK抑制剂,作用于JNK1, JNK2和 JNK4,IC50分别为 4.7 nM, 18.7 nM 和 1 nM,比作用于MNK2, Fms选择性高10倍以上,对c-Kit, Met, PDGFRβ没有抑制作用。
靶点
 JNK3  JNK1  JNK2 Kit (V559D,T670I)  Kit (V559D)   
IC50
 1 nM  4.7 nM  18.7 nM  56 nM  92 nM  
体外研究
 JNK-IN-8 inhibits c-Jun phosphorylation in HeLa and A375 cells with EC50 of 486 nM and 338 nM, respectively. JNK-IN-8 shows a dramatic improvement in selectivity and eliminated binding to IRAK1, PIK3C3, PIP4K2C, and PIP5K3. JNK-IN-8 requires Cys116 for JNK2 inhibition. JNK-IN-8 (10 mM) suppresses the IL-1β-stimulated phosphorylation of c-Jun in IL-1R cells, an established substrate of the JNKs. JNK-IN-8 covalently attaches to the JNK isoforms caused a small retardation in the electrophoretic mobility of the JNK isoforms. JNK-IN-8 is discovered to inhibit JNK kinase by broad-based kinase selectivity profiling of a library of acrylamide kinase inhibitors based on the structure of imatinib using the KinomeScan approach. JNK-IN-8 possesses distinct regiochemistry of the 1,4-dianiline and 1,3-aminobenzoic acid substructures relative to imatinib and uses an N,N-dimethyl butenoic acetamide warhead to covalently target Cys154. JNK-IN-8 adopts an L-shaped type I binding conformation to access Cys 154 located toward the lip of the ATP-binding site. 
体内研究
 
溶解性
可溶于DMSO
稳定性
2年 -20°C粉状,6月-80°C溶于DMSO

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7